TUBERCULOSIS BURDEN IN LEBANON(between NTP and LATA) By Dr Antoine SAADE President of LATA CAIRO – 57th CONFERENCE OF ESCT.

Slides:



Advertisements
Similar presentations
BSEC Working Group on Institutional Renewal and Good Governance March 26-27, 2007 Istanbul The Black Sea NGOs Network.
Advertisements

Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
CSD-18 ESCWA & Arab Region Regional Discussion Western Asia & Arab Region Outcome of the RIM on CSD-18 Thematic Areas Interactive Discussion Comments on.
HIV/ AIDS - Yemen Successes and challenges Dr. Fouzia Abdullah Gharama Programme Manager Ministry of Public Health & Population.
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
1 REGIONAL SYMPOSIUM ON ALZHEIMER’S DISEASE AND RELATED DISORDERS IN THE MIDDLE EAST October 1-2, 2005 Istanbul, Turkey DIANE MANSOUR ALZHEIMER’S ASSOCIATION.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Lobbying for Food Security: FAO advocacy interventions
European Heart Health Charter Official Launch 12 June 2007 European Parliament - Brussels "Every child born in the new millennium has the right to live.
Module 1: Course Overview. Course Objectives Teach you everything you need to know about the TB Program Describe TB the roles and responsibilities of.
Lebanon Introduction Based on studies of its past disasters, Lebanon can be considered as a country vulnerable to earthquakes because of some.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Strategy Development for Increasing Screening Participation Awareness and Resource Mobilization The Akbaraly Foundation experience.
THE ROLE OF ALZHEIMER ASSOCIATIONS IN CAMPAIGNING FOR CHANGE Marc Wortmann Alzheimer’s Disease International.
Bi-State TB Elimination April 10, 2014 Anna Frye Michelle Goodyear Tuberculosis: Recent Trends and Relevant Research.
ADAMOS ADAMOU, MEDICAL ONCOLOGIST MEMBER OF THE EUROPEAN PARLIAMENT.
The Global Fund to Fight AIDS, Tuberculosis and Malaria 5 th Replenishment Update May 6, 2015 Addis Ababa, Ethiopia 1.
Tajikistan The Global Fund to Fight AIDS, Tuberculosis and Malaria Support to the Strategic Plan to Prevent HIV/AIDS Epidemics in Tajikistan. November.
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
Tuesday, September 08, 2015 Perspective on TB/HIV community mobilization in Nigeria: contribution as member of the TB/HIV Core Group Obatunde Oladapo
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
O. Guidzheva Director of Information Center of Healthcare of MHMI.
Network of Networks of the Anna Lindh Foundation TRESMED4 Sofia, 3 June 2013.
GETTING READY FOR DUAL EMTCT VALIDATION IN THE AMERICAS Adele Schwartz Benzaken.
1. History of creation of STOP TB Partnership, Tajikistan Motivations: The need for joined efforts to fight TB; The voices and the needs of TB patients.
Natalya Podogova Chairman of the Board Charitable Foundation for Support of Priority Strategies in Public Health Russia Legislative Barriers for Harm Reduction.
Public-Private Partnerships -Selected Experiences in the Western Pacific & Cambodia- National Forum on Public-Private Partnership in Health 7 November,
Islamic Medical Association Beirut – Lebanon Arusha – Tanzania 7-8 August 2014 Presented By: Dr. Fouad Rifai President.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
ISTC The Indonesian Experience Erlina Burhan Indonesian Society of Respirology ISTC Task Force Indonesian Medical Association.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Regional IAWG Meeting Syria Presentation 20 th March 2012 Cairo, Egypt 1.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
Progress and plans for PPM in the WHO Region of the Americas Fifth PPM Subgroup Meeting June, Cairo.
Background Nature and function Rationale Opportunities for TB control Partnering process.
The Doha International Family Institute (DIFI) Research to advance Family Polices in the Arab World World Family Summit, 2015.
THE GLOBAL FUND SUSTAINING THE GAINS AND IMPACT Uganda November 2013.
Shornokishoree: An Innovative Approach to Promote Adolescent Girl’s Health & Development in Bangladesh Dr. Nizam Uddin Ahmed Executive Director & General.
Measures to Decrease TB Prevalence in the Barents Region Andrey O. Maryandyshev Elena I. Nikishova Dmitry V. Perkhin.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Current Aspects of TB in Egypt and other EMR countries Dr. Essam Elmoghazy Chairman of Cairo Association against Smoking, Tuberculosis and Lung diseases-
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
By Dr Antoine Saade WHO TB consultant and LATA president 24 March Beirut, Lebanon.
A strategic vision for regional cooperation in the Arab Region Arab States Round Table World Bank Land and Poverty Conference 2017 Washington, 21 March.
TB- HIV Collaborative activities in Romania- may 2006 status
Dr. Nuha H. Mohammed.
How does teamwork improve value. Dr Nils E
Maintaining Visibility 2009
TB Control in PHC network and Partners Coordination in Cambodia
Knowledge gaps in formulating TB Control Policies for Prisons
World Tuberculosis Day 2016
WHO global policy development process for TB/HIV
Update on SBCC Activities of Challenge TB Bangladesh
TB/HIV Working Group: Achievements
Vietnam Investment and Finance for TB
National Cancer Center
From TB control to integrated respiratory disease control
Introduction to poster session and discussion
The STOP TB Strategy – 2009 VISION: A TB-free world
Tuberculosis.
4TH TB/HIV WORKING GROUP GLOBAL MEETING
Pharmacy Sector SECTOR COMMITMENT TO END TB
5th edition NTP MANUAL OF PROCEDURES Chapter 1: Introduction
Presentation transcript:

TUBERCULOSIS BURDEN IN LEBANON(between NTP and LATA) By Dr Antoine SAADE President of LATA CAIRO – 57th CONFERENCE OF ESCT

GLOBAL TUBERCULOSIS HISTORY Tuberculosis is one of the oldest diseases, known in Egypt of pharaohs and other ancient civilizations. Until mid-1880s many believed TB was hereditary.It has been widely spread in the industrialized societies during the second half of the nineteenth century, and was the first cause of mortality during that time. In 1865 Villemin proved TB was contagious and the cause of the disease has been discovered by Robert Koch in 24 March This date remains essential on the TB agenda and became known as “World TB Day.“ First sanatorium established in US 1884 The first drug that could kill TB was discovered 1943

IMPORTANT DATES OF TB STRUGGLE IN LEBANON – The first medical society to fight TB 1906 – Establishing of the first sanatorium 1908 – Opening of the chest diseases clinic Karantina Beirut 1950 – Launch of UNRWA ward for Palestinians patients in sanatorium of Dahr el Bachek in the presence of the Director of UNRWA 1955 – The introduction of Rifampicin to the Lebanese market 1968 – Launching of the National Programme against Tuberculosis 1992

IMPORTANT DATES OF TB STRUGGLE IN LEBANON – Start implementation of the Dots strategy (DOTS) 1998 – DOTS all over 2000 – Treatment of MDR TB patients 2005 – Starting PAL strategy 2007 – Start using the fixed dose combination (FDCs)2007 – Launching of LATA 2014

HISTORICAL ASPECT of TB in LEBANON First period: 1900 to 1930 rest fresh air and adequate food Second period: ,surgical period, pneumothorax and other surgical treatments. Third period : Discovering of Anti –TB drugs and TB regimens Fourth period: period of civil war ( ), and emergence of TB drug resistance. Fifth period started with the launching of the National TB Program in 1992

Achievements of the Programme Foundation and activation of multiple TB centers covering all Lebanese regions. Close Collaboration between NTP, other public sectors and and private health sector. Cooperation and coordination with medical schools and unification of TB curricula, promoting ISTC. Creation of a laboratory network.

Achievements of the Programme Implementation of DOTS strategy in all Lebanese regions(since 2000) Drugs procurement without interruption since the foundation of the programme. Introduction of FDCs since Keeping a number of beds in sanatorium Starting the implementation of DOTS-PLUS strategy for MDR patients as of may 2005 Introducing by the year 2007 of the PAL strategy

TREND OF TB IN LEBANON

CHALLENGES The main challenge for the NTP is the increasing number of non national TB patients, especially Syrian displaced population 109 TB cases are detected during 2014 among Syrians when the expected number is turning around 400 to 500 TB patients.

NGOs AND TB CONTROL Many organizations were founded since the beginning of the 20 th century: the healthy TB Society shelter ( ), the society of General Women's pity ( ) and the TB control Association ( ). All these organizations were unified later under the name of “ Daher Elbachek TB control association”, which has become a member of the International Union Against Tuberculosis(the union). Recently, by the end of 2014, a new organization is born, LATA, the Lebanese Anti TB Association

WHAT IS LATA It is a Lebanese anti-TB association, operates on the Lebanese territory in order to control tuberculosis and seeks to achieve the MDG and the WHO strategy to END TB. Its actual role is the dissemination of information and TB data on a broader scale and through the media Support of TB patients and their families, according to the material possibilities of the association. Development of relationships with national and international organizations and participation into scientific meetings and conferences at the national and international levels.

LATA ACTIVITIES We are a young anti TB association, born by the end of Members of the association. Different background a strategic plan for the next 3 years has been elaborated Hotline to support all tuberculosis problems that could face doctors or patients in Lebanon. Conducting periodical conference at provincial level(TB in Lebanon, MDR….)

NATIONAL ACTIVITIES LATA participated to the 1er CONGRES DE LUTTE CONTRE LES INFECTIONS ASSOCIEES AUX SOINS(11 September 2015) Beirut –Lebanon and presented profile of MDR at global and national level LATA prepared and managed the memorization of TB day, 24 Mach 2016, Beirut Lebanon The event was celebrated with eminent international and national speakers(including Egypt representative)

INTERNATIONAL ACTIVITIES First international activity was in collaboration with WHO, during November 2015 in Addis Ababa, Ethiopia. the selection of WHO consultation with NGOs and CSOs was based on online consultation during July-August 2015, with 700 NGOs from 73 countries. 89 NGOs from 37 countries have been selected(including LATA Lebanon) and more than 150 participants.(including LATA president) Our participation to the 57 th conference of ESCT.

PRIORITIES OF LATA Continue the cycle of advocacy and awareness about TB Management of vulnerable and special population as MDR, TB/HIV, prisoners, displaced population and refugees. Under the umbrella of the MOPH-Lebanon, prepare a strategic plan to control and eliminate TB Join our effort for the TB elimination in the eastern Mediterranean region Prepare a plan for joint action on the level of Arab Eastern Mediterranean countries (pan Arab TB association)

THANKS FOR YOUR ATTENTION LATA LEBANON